Identification of HMX1 target genes: a predictive promoter model approach. by Boulling, A. et al.
The homeobox (HMX) family of transcription factors is 
characterized by the presence of a 60-amino acid homeobox 
domain. Currently, this family contains four members: HMX1, 
HMX2, HMX3 (also known as Nkx5–3, Nkx5–2, and Nkx5–1, 
respectively), and sensory organ homeobox 1 (SOHo1) 
[1]. Expression of HMX1, HMX2, and HMX3 is highest in 
the sensory organs, I.E., the eye and inner ear, and in the 
peripheral and central nervous systems [2,3]. During mouse 
development, Hmx1 is expressed in the trigeminal ganglion 
and in the second branchial arches early as E9.5, and in the 
dorsal root ganglia at E10.5. Later on, Hmx1 is expressed in 
the lens, in the neural epithelium of the eye, in the sympathic 
and vagal nerve ganglia, and in the mesenchyme near the 
developing ear [4]. More recently, the discovery of an HMX1 
loss-of-function mutation responsible for a new oculoau-
ricular syndrome (MIM 612109) in a Swiss consanguineous 
family prompted us to evaluate the role of this transcription 
factor [5].
In 2009, the description of two mutant mice called 
“dmbo” and “misplaced ears” exhibiting microphthalmia, 
in addition to ear and cranial malformations, was reported. 
Mapping and sequencing analyses of these mice revealed a 
nonsense mutation in the first exon of Hmx1 in dmbo and 
a frameshift mutation in exon 2 of “misplaced ears” mice 
[6]. The absence of Hmx1 protein in dmbo was further 
confirmed in a study showing that Hmx1 was required for 
the normal development of somatosensory neurons in the 
geniculate ganglion [7]. Moreover, a dmbo rat strain with a 
similar phenotype and a deletion in an ancient distal puta-
tive enhancer of Hmx1 was described recently [8]. All these 
rodent mutants underline the prominent role of Hmx1 in eye 
development and represent good models.
Despite these recent advances, the role of Hmx1 in tran-
scriptional regulation remains widely unknown. A major 
challenge in deciphering the Hmx1 pathway involved in eye 
development is identifying target genes. However, this repre-
sents a difficult task as no HMX1 chromatin immunoprecip-
itation-grade antibody seems to exist in the mouse. There-
fore, we constructed a predictive promoter model (PPM). 
This approach is based on the analysis of differentially 
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Purpose: A homozygous mutation in the H6 family homeobox 1 (HMX1) gene is responsible for a new oculoauricular 
defect leading to eye and auricular developmental abnormalities as well as early retinal degeneration (MIM 612109). 
However, the HMX1 pathway remains poorly understood, and in the first approach to better understand the pathway’s 
function, we sought to identify the target genes.
Methods: We developed a predictive promoter model (PPM) approach using a comparative transcriptomic analysis in 
the retina at P15 of a mouse model lacking functional Hmx1 (dmbo mouse) and its respective wild-type. This PPM was 
based on the hypothesis that HMX1 binding site (HMX1-BS) clusters should be more represented in promoters of HMX1 
target genes. The most differentially expressed genes in the microarray experiment that contained HMX1-BS clusters 
were used to generate the PPM, which was then statistically validated. Finally, we developed two genome-wide target 
prediction methods: one that focused on conserving PPM features in human and mouse and one that was based on the 
co-occurrence of HMX1-BS pairs fitting the PPM, in human or in mouse, independently.
Results: The PPM construction revealed that sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) (Sgcg), 
teashirt zinc finger homeobox 2 (Tshz2), and solute carrier family 6 (neurotransmitter transporter, glycine) (Slc6a9) 
genes represented Hmx1 targets in the mouse retina at P15. Moreover, the genome-wide target prediction revealed that 
mouse genes belonging to the retinal axon guidance pathway were targeted by Hmx1. Expression of these three genes 
was experimentally validated using a quantitative reverse transcription PCR approach. The inhibitory activity of Hmx1 
on Sgcg, as well as protein tyrosine phosphatase, receptor type, O (Ptpro) and Sema3f, two targets identified by the PPM, 
were validated with luciferase assay.
Conclusions: Gene expression analysis between wild-type and dmbo mice allowed us to develop a PPM that identified 
the first target genes of Hmx1.
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co-expressed genes between two different biologic states and 
represents a powerful tool as was recently shown [9]. In our 
case, we used a comparative transcriptomic analysis between 
retinas at postnatal day 15 (P15) of wild-type (WT) and dmbo 
mice. Basically, a promoter model is defined as a framework 
of two or more transcription factor binding sites (TFBSs) with 
a defined distance range and strand orientation. In a given 
promoter, a functional pattern involving multiple TFBSs is 
called a cis-regulatory module (CRM). CRMs represent the 
next level of organization after individual TFBSs and are 
often involved in tissue-specific expression (reviewed in [10] 
and [11]). The promoter model is called predictive when it 
is based on a functional hypothesis instead of the analysis 
of experimentally validated TFBSs. In theory, the promoter 
model represents a specific and flexible structure shared by 
the promoter of genes belonging to the same pathways.
Despite the lack of knowledge about Hmx1, critical 
information was sufficient to identify specific features 
about the gene’s target. In fact, Amendt et al. showed that 
HMX1 binds to the canonical CAAGTG sequence and acts 
as a transcriptional antagonist of Nkx2-5, a well-studied 
transcription factor that recognizes a consensus sequence 
TNAAGTG overlapping HMX1-BSs [12]. The mouse and rat 
ANF proximal promoters include two validated Nkx2-5-BSs 
involved in transcriptional activation. Additional sites are 
located in distal enhancer regions upstream of the transcrip-
tion start site (TSS) [13-15]. Similar Nkx2–5-BSs clusters 
have also been observed in the H15 mid locus of Drosophila. 
The functionality of one of them has been demonstrated 
in cardioblasts [16]. This type of CRM involving multiple 
similar TFBSs is called homotypic CRMs, or homotypic 
clusters of TFBSs, and is widely represented in proximal 
promoters and enhancers of mammals and invertebrates [17]. 
This observation is particularly true for TFBSs of several 
TFs, including Nkx2–5.
To identify targets of HMX1, we developed a PPM based 
on HMX1-BSs clusters, with analogy to Nkx2–5. We report 
the first Hmx1 targets in the mouse retina at P15. Moreover, 
applying our PPM to mouse and human genomes allowed 
us to identify additional potential target genes involved in 
embryonic eye development.
METHODS
Animal handling and tissue isolation: The studies adhered to 
the Association for Research in Vision and Ophthalmology 
(ARVO) Statement for the Use of Animals in Ophthalmic 
and Vision Research and were approved by the Veterinary 
Service of the State of Valais (Switzerland). WT C57BL/6J 
mice were obtained from Janvier (Le Genest St Isle, France) 
and dmbo mice from Jackson Laboratory (Bar Harbor, ME). 
Dmbo mice were backcrossed with C57BL/6JWT mice for 
three additional generations to obtain a homogeneous genetic 
background and to remove the Rd1 mutation they unexpect-
edly carried. All mice were genotyped with polymerase chain 
reaction analysis of DNA tails. Animals were maintained in a 
12 h:12 h light-dark cycle with free access to food and water. 
Mice were killed by cervical dislocation at P15 or P60, and 
their eyes were enucleated. Retinas were isolated under a 
microscope to remove extra retinal tissue and snap-frozen 
at −80 °C.
RNA extraction and dosage: Total RNA was individu-
ally isolated from each whole retina and purified using the 
RNeasy minikit (Qiagen, Basel, Switzerland) as described 
by the manufacturer. RNA quantities were assessed with a 
NanoDrop ND-1000 spectrophotometer (Thermo Scientific, 
Wilmington, DE). Four and three different animals for each 
condition were used for microarray and reverse transcription 
polymerase chain reaction (RT–PCR), respectively.
Microarray procedure: RNA quality was assessed using 
RNA 6000 NanoChips with the Agilent 2100 Bioanalyzer 
(Agilent, Palo Alto, CA). For each sample, 100 ng of total 
RNA were amplified using the WT sense strand Target 
Labeling kit (Affymetrix, Santa Clara, CA); 5.5 µg of the 
resulting sense cDNA was fragmented with uracil DNA 
glycosylase (UDG), apurinic/apyrimidic endonuclease 1 
(APE 1), and biotin-labeled with terminal deoxynucleo-
tidyltransferase (TdT) using the GeneChip WT Terminal 
labeling kit (Affymetrix). Affymetrix Mouse Gene 1.0 ST 
arrays were hybridized with 2.7 µg of biotinylated target for 
17 h at 45 °C, washed, and stained according to the protocol 
described in the Affymetrix GeneChip Expression Analysis 
Manual (Fluidics protocol FS450_0007). The arrays were 
scanned using the GeneChip Scanner 3000 7G (Affymetrix), 
and raw data were extracted from the scanned images and 
analyzed with the Affymetrix Power Tools software package. 
All statistical analyses were performed using the free high-
level interpreted statistical language R (version 2.12.1) and the 
Bioconductor package limma (version 3.6.9). Hybridization 
quality was assessed using the Expression Console software 
(Affymetrix). Normalized expression signals were calculated 
from Affymetrix CEL files using the RMA normalization 
method. Differential hybridized features were identified 
using Bioconductor package “limma” that implements 
linear models for microarray data [18]. The p values were 
adjusted for multiple testing with Benjamini and Hochberg’s 
method to control for the false discovery rate (FDR) [19]. 
Probe sets showing at least 1.2-fold change and a FDR<0.1 
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were considered significant. Gene expression data have been 
deposited in GEO (GSE47002).
Functional annotation of microarray data: Differentially 
expressed genes (FDR<0.1) were annotated in accordance 
with the Gene Ontology (GO) classification system. GO terms 
were classified into categories related to molecular function, 
cell component, and biologic process to assess the statis-
tical enrichment of differentially expressed genes in these 
categories compared with the full mouse genome. Annotation 
and statistical calculation were realized using the DAVID 
algorithm [20,21]. In addition, the MetaCore software from 
GeneGo was used to highlight the most relevant GeneGO 
process networks. Each process represents a preset network 
of protein interactions characteristic of the process. For the 
DAVID and MetaCore enrichment analyses, only results with 
a p value <0.1 were considered. MetaCore and DAVID use a 
hypergeometric model to determine the significance of the 
enrichment.
Predictive promoter model construction and validation: All 
sequences were collected via the UCSC Main Table Browser 
of the online Galaxy Platform (https://main.g2.bx.psu.edu/). 
We used the July 2007 (NCBI37/mm9) and February 2009 
(GRCh37/hg19) genome assemblies’ versions, and genes 
absent in the refGene table were retrieved in GenBank and 
checked manually. All gene accession numbers related to 
the genes cited in the article are summarized in Appendix 1. 
[-250;+250] region selection and motif combinations analyses 
in the (+) and (-)-training sets were obtained from Galaxy. The 
(-)-training set was constituted by random selection of 2,000 
RefSeq gene promoter sequences. Finally, statistical valida-
tion of the model was performed with Fisher’s exact test. PPM 
specificity and sensitivity were calculated with MedCalc. 
Cell-specific expression levels of Hmx1, sarcoglycan, gamma 
(35kDa dystrophin-associated glycoprotein) (Sgcg), teashirt 
zinc finger homeobox 2 (Tshz2), and solute carrier family 
6 (neurotransmitter transporter, glycine) (Slc6a9) were 
retrieved in the gene expression profile database [22].
Predictive promoter model–based genome-wide target 
predictions: All the [-250,+200] sequences fitting the PPM 
were selected from human and mouse RefSeq databases. 
PPM-based selection focused on the conserved HMX1-BS 
pairs was realized by crossing the human and mouse previ-
ously obtained selections. Sequences containing more than 
two HMX1-BSs were analyzed to achieve the target genes 
selection based on the co-occurrence of HMX1-BS pairs. 
Axon guidance pathway enrichment analysis was based on 
the KEGG database and performed for the mouse predicted 
target selection obtained with the PPM co-occurrence based 
method. The statistical enrichment was assessed against the 
full mouse genome by considering the 25,504 unique genes of 
the ccds table, with the χ2 and Yates’ correction test.
Quantitative rt-PCR: Reverse transcription was performed 
with 500 ng RNA, 25 ng/µl OligodT, 1 mM each dNTP, 
10 mM dithiothreitol, 2 U/µl RNaseBlock, and 1 µl Affini-
tyScript (Agilent) in a final volume of 20 µl at 42 °C for 1 h. 
The reaction was then maintained at 70 °C for 15 min, and 
the cDNA obtained was 1:10 diluted. Quantitative PCR was 
performed in a 25-µl mixture containing 12.5 µl of FastStart 
Universal SYBR Green Master (ROX; Roche, Basel, Swit-
zerland), 10 µl of diluted cDNA, and 0.3 µM of primer pairs 
(Appendix 2). The PCR program had an initial denaturation 
at 95 °C for 10 min, followed by 40 cycles of denaturation at 
95 °C for 30 s, annealing at 55 °C for 1 min, and extension at 
72 °C for 1 min. All PCRs were realized in triplicate. Tran-
script levels were normalized using the Gapdh housekeeping 
gene and analyzed with the Student t test. All qPCR efficien-
cies were calculated from the slope of a standard dilution 
curve to allow relative comparison of gene mRNA levels.
Immunohistochemistry: Enucleated eyes were fixed for 45 
min at 4 °C in 4% paraformaldehyde and were cryoprotected 
by 30% sucrose. The eyes were then embedded in freezing 
compound (30% Albumin/3% gelatin in 1x phosphate-
buffered saline (PBS): 154 mM NaCl, 1 mM KH2PO4, 3 mM 
Na2HPO4 heptahydrate) and vertically sliced 10 μm thick in a 
cryostat. Sections were washed three times with PBS, treated 
with blocking buffer (2% native goat serum containing 0.2% 
Triton X-100) at room temperature for 10 min, and left over-
night at 4 °C with the anti-SGCG primary antibody (Protein-
tech, Chicago, IL) diluted 1:100. Controls were prepared by 
omitting the primary antibody during the incubation. The 
following morning, sections were rinsed three times with 
PBS, blocked for 10 min, and incubated at room temperature 
for 1 h with Alexa Fluor 594 goat antirabbit immunoglobulin 
(Invitrogen, Zug, Switzerland) secondary antibody diluted 
1:1,500. After three additional washings, the sections were 
stained with 4’,6-diamidino-2-phenylindole dihydrochloride 
diluted 1:1,500 for 10 min at room temperature, washed three 
times again, and mounted with Citifluor AF1 (Citifluor Ltd, 
Leicester, UK). The stained slides were imaged on a Zeiss 
microscope, and image analysis was performed using the 
ZEN lite 2011 software (Zeiss, Zürich, Switzerland).
Construction of reporter and expression plasmids: PCR 
primer pairs used for molecular cloning were designed to 
generate an amplicon spanning the TSS of Sgcg, Sema3f, and 
Ptpro and to carry all the HMX1-BS identified in the prox-
imal promoter region. All promoter regions were amplified 
with the PfuUltra High-Fidelity DNA Polymerase (Agilent) 
according to the manufacturer’s instructions. Mouse Sgcg, 
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Sema3f, and Ptpro promoter regions were amplified using 
the following primer pairs carrying MluI and XhoI restric-
tion sites (underlined), with indicated annealing temperatures 
(Ta): 5′-GCG CAC GCG TCA AAG ACA CGT CAG CCT 
CAG-3′ and 5′-GCG CCT CGA GGA AAC GCT GTA CCT 
ATC TGA TTT ACA-3′ (Sgcg, Ta=61 °C), 5′-GCG CAC 
GCG TGC AAG AGT GTA TGG GGA AGG-3′ and 5′-GCG 
CCT CGA GCA GGC CTC TCA GCA GGTG-3′ (Sema3f, 
Ta=63 °C), 5′-GCG CAC GCG TCA TGG AAA TCG TTG 
CTT GTG-3′ and 5′-GCG CCT CGA GCG GCG TTG TTT 
AAT GGC TAA-3′ (Ptpro, Ta=60 °C). Amplified DNA frag-
ments were inserted into the pGL3-basic vector with the XhoI 
and MluI restriction enzymes to produce pGL3-Sgcg, pGL3-
Sema3f, and pGL3-Ptpro reporter constructs. Before the 
cloning step, the CAAGTG site located just upstream of the 
multiple cloning site in the pGL3-basic vector was converted 
to TAATCA by site-directed mutagenesis. The Hmx1 mouse 
cDNA was amplified with PfuUltra High-Fidelity DNA Poly-
merase using 5′-ATG CCG GAT GAG CTG ACC G-3′ and 
5′-TCA CAC TAG CCC CGG CAT C-3′ primers (Ta=60 °C), 
and then inserted into the pcDNA3.1 vector (pcDNA3.1-
Hmx1) with the pcDNA3.1/V5-His TOPO TA Expression 
Kit (Invitrogen).
Cell culture and transfection: Mouse neuroblastoma cells (aka 
Neuro-2a or N2a) were grown in Dulbecco’s Modified Eagle 
Medium (DMEM; PAA, Cölbe, Germany) supplemented with 
10% fetal bovine serum and 100 µg/ml Normocin (Invivogen, 
Toulouse, France). Twenty-four hours before transfection, 
200,000 cells/well were seeded in 12-well plates. For one 
transfection, 900 ng of one pGL3 reporter construct, 900 
ng of pcDNA3.1-Hmx1 or empty pcDNA3.1, and 300 ng of 
pCMV-Beta-Gal control plasmid were mixed together with 
4 µl jetPEI (Polyplus, Illkirch, France) and dropped onto the 
cells.
Luciferase reporter gene assay: Forty-eight hours after trans-
fection, cells were rinsed with PBS and lysed with 100 µl 
potassium phosphate buffer (100 mM K2HPO4, pH7.8, 0.2% 
Triton X-100). After centrifugation, 5 µl supernatant from 
each sample were added to 20 µl Firefly luciferase reagent. 
In parallel, 10 µl supernatant from each sample were added to 
100 µl β-galactosidase reagent. The relative luciferase activity 
was determined by dividing the luminescence of Firefly 
luciferase activity by that of the cotransfected β-galactosidase 
activity. The experiment was performed three times for 
each reporter construct, and transfections were realized in 
triplicate for each experiment. The significance between the 
luciferase activity of each reporter construct cotransfected 
with pcDNA3.1-Hmx1 and with pcDNA3.1 was then assessed 
for significance with the Student t test.
Statistical analysis: The statistical tests used in this study are 
detailed at the end of the microarray procedure, functional 
annotation of microarray data, PPM construction and valida-
tion, quantitative reverse transcription PCR, and luciferase 
reporter gene assay sections.
RESULTS
Comparative transcriptomic analysis: The comparative tran-
scriptomic analysis of the mouse retina between the dmbo 
and WT C57BL/6J mice was realized at P15 to avoid killing 
pregnant dmbo mice and to obtain a sufficient amount of 
tissue. The retina is still developing at this age and is always 
expressing Hmx1. The analysis showed 146 differentially 
expressed genes (70 up and 76 down) with a FDR<0.1 and 
at least 1.2-fold change (Figure 1A, Appendix 3, Appendix 
4). Thirty of these genes were highly confident and had a 
FDR<0.01 (14 up and 16 down). Analysis of the 146 differ-
entially expressed genes with the MetaCore software from 
GeneGo showed ten enriched GeneGO process networks 
with p<0.1 (Figure 1B). The first three ranked processes 
are the synaptogenesis (p=0.008879), the visual perception 
(p=0.009481), and the synaptic contact (p=0.009713). In 
another approach, the DAVID software allowed us to clas-
sify these genes into GO categories, showing that nine of 
them were significantly enriched with p<0.1 in molecular 
function, three in cell component, and 20 in biologic process 
categories (Appendix 5). All of the enriched molecular func-
tion categories were related to ion and vitamin binding or 
transmembrane transport, and all the enriched cell component 
categories were related to cell projection terms as axoneme 
and cilium. Enriched biologic process categories were more 
numerous and diversified and concerned, for example, organ-
elle localization or metal ion homeostasis.
Hmx1 target promoter model construction and validation: 
As explained above, we hypothesized that multiple Hmx1 
sites could form CRMs and act in synergy, as observed for 
Nkx2–5 [17]. In this regard, we postulated that the number of 
motifs could play a role in the transcriptional regulation of 
Hmx1 targets. To elaborate our predictive promoter model, we 
used the promoter sequences of the most confident differen-
tially expressed genes (FDR<0.01 group) and considered the 
number of CAAGTG motifs present. We used a screening 
window ranging in size from −250 to +200 nucleotides (nt) 
around the TSS. This window was based on the size of the 
proximal promoter and the approximate median size of the 
eukaryote 5′ untranslated region (UTR), two regions known 
to be enriched in TFBS [23,24]. The CAAGTG motifs 
located in the [-250,+200] interval were counted. Three of 
the 30 genes contained two motifs, three contained one motif, 
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and the last 24 did not contain any motif. The three genes 
containing two motifs, considered theoretical Hmx1 targets, 
were used to generate a framework (Figure 2A–B) that should 
correspond to a feature specific for Hmx1 target promoters. 
The orientation of the motifs was disregarded, but we consid-
ered the space between the two motifs and kept a distance 
range spanning from 90 to 190 nt. Unexpectedly, only one 
HMX1-BS in the Tshz2 promoter was strictly conserved 
between human and mouse.
This theoretical promoter model is predictive and must 
be statistically validated, as it is based on arbitrary criteria. 
Therefore, we calculated the enrichment of this particular 
feature between the FDR<0.01 group (used as the positive 
(+)-training set) and a control group of random promoters 
(used as the negative (-)-training set). We observed a 22.2-
fold significant enrichment (p=0.0006) of the PPM specific 
feature in the (+)-training set compared to the (-)-training 
set within the [-250,+200] region (Figure 2C). This enrich-
ment was also observed in the FDR<0.1 group but to a lesser 
extent (p=0.0091). There was no significant enrichment when 
the genes containing at least one motif were considered. 
From these data, we concluded that the high enrichment of 
this particular feature in the (+)-training set validated our 
promoter model and supported the idea that Sgcg, Tshz2, and 
Slc6a9 were direct Hmx1 targets.
To complete our approach, we also tried to build a PPM 
with lower specificity and higher sensitivity. For this, we 
replaced the canonical sequence CAAGTG with the minimal 
core motif CAAG also able to bind HMX1 but with a lower 
affinity [12]. We generated a low specific PPM (LS-PPM) 
and a very low specific PPM (VLS-PPM) fitting the same 
distance and orientation criteria than the initial PPM, but 
carrying one or two CAAG in place of the canonical HMX1-
BS, respectively (Table 1). Both retrieved a better rate of 
positive genes but showed low specificity (1.37- and 1.01-fold 
enrichment for LS-PPM and VLS-PPM, respectively). These 
two PPMs with lower specificity were not reused for the 
following analyses.
Characterization of Sgcg, Tshz2, and, Slc6a9 expression: To 
minimize the possibility that Sgcg, Tshz2, and Slc6a9 were 
false positive targets of Hmx1, we confirmed their level of 
deregulation between eyes from dmbo and WT mice, and 
checked for colocalization with Hmx1. The retina is made of 
many different cell types with specific expression profiles. 
We therefore assessed the expression of Hmx1, Sgcg, Tshz2, 
and Slc6a9 with qPCR (Figure 3A) and looked for their 
precise cell subtype expression in the mouse retina, according 
to an online gene expression profile database [22] (Figure 
3B). Transcript quantification confirmed that Sgcg and 
Tshz2 were overexpressed in dmbo at P15, whereas Slc6a9 
was underexpressed. This deregulation tended to disappear 
at P60 for Tshz2 and Slc6a9, but remained extremely high for 
Sgcg. As expected, the inspection of a retina-specific data-
base revealed a strong overlap of Hmx1, Slc6a9, and Tshz2 
expression in the glycinergic amacrine cells. Sgcg expression 
was not detected in the microarray database probably due to 
the weak level of mRNA, as shown with qPCR. However, 
the γ-sarcoglycan protein encoded by Sgcg was detected with 
immunohistochemistry in the ganglion cell (GCL), the inner 
plexiform (IPL), the inner nuclear (INL), and the outer plexi-
form layers (OPL; Figure 3C), as already shown by Fort et 
al. [25]. No difference in protein expression of γ-sarcoglycan 
Figure 1. Summary of microarray 
results. A: Up- and downregulated 
genes with a fold-change >1.2 and 
a FDR<0.1 or <0.01. B: MetaCore 
GeneGO Process Networks enrich-
ment analysis of the FDR<0.1 group 
of differentially expressed genes. 
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was observed between the WT and dmbo samples (data not 
shown). The immunohistochemistry staining was higher 
in some cells of the INL exhibiting a disposition pattern 
characteristic of the amacrine cells, at the delimiting border 
between the INL and the IPL. This result was in accordance 
with colocalization of Sgcg and Hmx1 expression.
Predictive promoter model–based genome-wide screening for 
HMX1 putative targets: Our model was based on a compara-
tive transcriptomic analysis realized in the mouse retina at 
P15. However, Hmx1 is highly expressed in the mouse eye as 
early as E10.5 suggesting an important role in development. 
Assuming that the PPM we developed was specific for HMX1 
targets (with 0.45% versus 10% representation in the (-) and 
(+)-training sets, respectively), we decided to screen the full 
human and mouse genomes. This global approach should 
provide an exhaustive view of all putative HMX1 targets, 
including those expressed during embryonic eye develop-
ment. As the first step, we used the PPM to screen mouse and 
human RefSeq databases via the Galaxy platform. These two 
databases contained a total of 30,490 and 43,695 sequences 
respectively, which corresponded to all transcripts of refer-
ence, including all isoforms and alternative promoters. We 
considered for each gene all potential alternative promoters 
whereas all redundant promoter sequences due to alternative 
splicing were discarded. The gene accession numbers of all 
isoforms corresponding to our predicted genes are listed in 
Appendix 1.
Screening of the full mouse RefSeq database using the 
PPM within the [-250,+200] region retrieved 157 sequences 
corresponding to unique protein-coding genes (Figure 4A, 
Appendix 1). Similarly, the screening of the human genome 
retrieved 100 sequences corresponding to unique protein-
coding genes. This approach allowed us to generate an 
exhaustive list of all possible HMX1 targets, but the high 
number of positive hits resulted in some difficulties with their 
interpretation. In fact, some of these genes were probably 
Figure 2. Elaboration and statistical 
validation of an Hmx1 predictive 
promoter model. A: Flowchart 
of the predictive promoter model 
(PPM) construction. #Location of 
CAAGTG motifs within proximal 
promoter or 5’UTR region is given 
in (B). B: Details of Sgcg, Tshz2, 
and Slc6a9 promoter structure. 
Forward (CAAGTG) and reverse 
(CACTTG) HMX1 binding sites 
(HMX1-BSs) are symbolized by 
black and white triangles, respec-
tively. The H letter indicates an 
HMX1-BS that is strictly conserved 
in human. C: Statistical validation 
of the PPM. Columns represent the 
percentage of promoters carrying 
at least 1 HMX1-BS or fitting the 
PPM in each group. Promoter count 
details are indicated for the false 
discovery rate (FDR)<0.1 group 
and the (+)-training set (FDR<0.01 
group). *p<0.01, **p<0.001.
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Figure 3. Characterization of Sgcg, Tshz2, and Slc6a9 expression. A: Quantitative reverse transcription polymerase chain reaction (qPCR) 
analysis of Sgcg, Tshz2, and Slc6a9 expression in wild type (WT), heterozygous (HT), and dmbo whole retina at P15 and P60. The significance 
of the differences between the WT and HT or dmbo mean mRNA expression levels were determined by three independent experiments 
done in triplicate. All qPCR efficiencies were above 1.96 with a Pearson’s r above 0.99. The mRNA levels are expressed as a ratio of the H6 
homeobox family 1 (Hmx1) WT level, in P15 and P60 experiments, independently. Bars, SD; *p<0.01, **p<0.05, ***p<0.001. AU, arbitrary 
units. B: Heatmap representation of Hmx1, Sgcg, Tshz2, and Slc6a9 expression in the different cell types of the mouse retina according to 
the gene expression profile database [22]. C: Immunostaining of γ-Sarcoglycan in the WT and dmbo retina at P15. White arrows indicate 
an accumulation of γ-Sarcoglycan at the border delimitating the INL and the IPL. DAPI, 4’,6-diamidino-2-phenylindole dihydrochloride 
staining; Merge, overlap between DAPI and γ-SG immunostaining. ONL, Outer nuclear layer; OPL, Outer plexiformlayer; INL, Inner nuclear 
layer; IPL, Inner plexiform layer; GCL, Ganglion cell layer.
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true HMX1 targets, but several could also be false-positives, 
representing targets related to TFs with the same binding sites 
(for example, HMX3 or NKX2–5). To improve the selectivity 
of the analysis and to focus on the most interesting candidate 
genes, we decided to add additional filters.
Initially, we developed a PPM approach based on 
conserving the HMX1-BS pairs between human and mouse. 
In fact, comparative genomics is one of the usual methods 
that aimed at discriminating functional TFBSs from irrel-
evant ones (reviewed in [11]). To maintain relative flexibility, 
our method was based only on the presence of an HMX1-BS 
pair and did not implicate a strict conservation of the posi-
tions or orientations of the HMX1-BSs between the two 
species. As already demonstrated, traditional approaches, 
similar to phylogenetic footprinting, give good predictions 
but are also likely to miss important conserved regulatory 
elements [26]. Crossing the two data sets showed that only 
ten genes contained the PPM features in both species (Figure 
4B). These genes were classified according to the localization 
of their expression.
In a second phase, we used another PPM approach 
based on the cooccurrence of HMX1-BS pairs, driven by the 
basic idea that increasing the number of HMX1-BS in the 
promoter region should increase their interaction with HMX1. 
This phenomenon should result in more efficient transcrip-
tion regulation. To assess this hypothesis, we looked at the 
HMX1-BS occurrence in all the mouse and human promoter 
sequences fitting the PPM. We observed that the promoter 
regions contained a maximum of four HMX1-BSs within the 
[-250,+200] window. Always in accordance with the PPM 
criteria, we determined that three sites might form three 
different homotypic HMX1-BS pairs (P1–2,P1–3,P2–3), even if it 
is unlikely that all three pairs could be considered at the same 
time due to the minimum distance range constraint of 90 bp 
(Figure 5A). Similarly, four sites might lead to a maximum 
of five combinations (P1–2, P1–3,P2–3, P2–4, P3–4). A single given 
site can be involved in multiple combinations. The screening 
of the mouse genome with this method retrieved nine genes 
with three sites allowing two different pair combinations, and 
one gene (Ephrin type-A receptor 6; Epha6) with four sites 
allowing three different pair combinations (Figure 5B). Inter-
estingly, three of these ten genes (Epha6, Ptpro, and Sema3f ) 
are expressed in the retina and are involved in axonal growth 
repulsion (see discussion). It represents a 56.6-fold enrich-
ment (p<0.0001) in the mouse axon guidance KEGG pathway 
(mmu04360). Ptpro was incorporated within the pathway 
although this gene was not initially reported in the KEGG 
database, in spite of Ptpro’s role as a guidance cue in retinal 
neurons [27,28]. Moreover, a deeper examination of Epha6 
showed an additional HMX1-BS at position [+245,+250] and 
an additional HMX1-BSs cluster fitting the PPM within the 
first intron (Figure 5C). Among the mouse HMX1-BSs, two 
were conserved in the human EPHA6 proximal promoter. One 
was unique to the human gene. With a similar approach, we 
identified eight genes with three sites allowing two interac-
tions in the human genome (Figure 5B).
Experimental validation of several predicted targets with 
luciferase assay: We experimentally validated some of these 
results with luciferase assays performed in N2A cells. We 
first assessed the reliability of our system by cotransfecting 
the pGL3-Sgcg positive control reporter construct with the 
pcDNA3.1-Hmx1 expression construct. Hmx1 cotransfection 
decreased pGL3-Sgcg luciferase expression by 71%, which 
was expected given the dmbo qPCR Sgcg results (Figure 6). 
Cotransfection of Hmx1 repressed pGL3-Ptpro and pGL3-
Sema3f luciferase expression by 50% and 66%, respectively.
Figure 4. Predictive promoter 
model–based genome-wide target 
selection focused on the conserved 
HMX1-BS pairs. A: Flowchart 
of the predictive promoter model 
(PPM)-based genome-wide target 
selection. B: Venn diagram illus-
trating the overlap between human 
and mouse target selections. 
Expression localization in the eye 
is indicated for genes carrying an 
HMX1-BS pair in both species.
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DISCUSSION
The major goal of this study was to identify target genes of 
Hmx1 in the mouse retina. The integration of in vitro data 
from Ament et al. and our in vivo microarray data allowed 
Figure 5. Predictive promoter model–based genome-wide target selection focused on the co-occurrence of HMX1-BS pairs. A: Simulta-
neous possible combinations of HMX1-BS pairs allowed by the predictive promoter model (PPM) with three or four HMX1-BSs. Pairs are 
identified according to HMX1-BSs numbers. B: Flowchart of the mouse and human PPM-based selections filtering according to HMX1-BS 
pairs counting. #See Figure 4 for details regarding the PPM-based selection process. Expression localization in the retina is indicated for 
genes carrying multiple HMX1-BS pairs. Significant enrichment in the axon guidance pathway is also indicated (see the text). C: Details of 
human and mouse EPHA6 structure in the region surrounding the transcription start site (TSS). Forward (CAAGTG) and reverse (CACTTG) 
HMX1-BSs are symbolized by black and white triangles, respectively. Distances (bp) between HMX1-BSs are indicated in red.
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us to obtain a clear picture of the typical basic structure of 
an HMX1 target promoter [12]. In addition, experimental 
controls concerning transcript amounts, expression colo-
calization, and luciferase assay strongly supported these 
findings.
The microarray data yielded the first set of informa-
tion about the molecular phenotype of the dmbo retina. The 
MetaCore analysis underlined that a lack of HMX1 protein 
altered synaptogenesis and visual perception, two biologic 
processes occurring at P15 [29]. At this time, we cannot say 
whether these observations were directly linked to Hmx1 
loss of activity or if they derived from anterior impairments 
occurring during eye development.
Then, we used the microarray data to construct a high 
specific PPM based on HMX1-BS clusters. It revealed that 
Sgcg, Tshz2, and Slc6a9 were Hmx1 targets in the mouse 
retina at P15. Using degenerated binding motifs for PPM 
construction, such as the minimal CAAG core motif, led 
to higher sensitivity but also to low specificity with no 
significant enrichment. Such a low specific PPM cannot 
be used for prediction because the model would probably 
yield an extremely high number of false positives. However, 
we thought that Hmx1 probably binds degenerate motifs in 
vivo, but no position weight matrix is currently available to 
perform a better PPM for Hmx1. Moreover, the sensitivity of 
the original PPM is likely underestimated because some of 
the differential expressions observed for genes belonging to 
the (+)-training set probably result from secondary events and 
are not directly linked to Hmx1.
The expression of Hmx1, Tshz2, Slc6a9, and probably 
Sgcg was observed in the glycinergic amacrine cells, a 
cell type that establishes synaptic contacts with rod-driven 
bipolar cells and play an important role in neurotransmission. 
Tshz2 is involved in an axonal growth network in the mouse 
Figure 6. Transcriptional repres-
sion of predicted target genes by 
the H6 homeobox family 1 gene. 
The pGL3-Sgcg (positive control), 
pGL3-Sema3f, and pGL3-Ptpro 
reporter plasmids were cotrans-
fected with the empty pcDNA3.1 
or the pcDNA3.1-Hmx1 expression 
vectors into the N2A cells. For 
each gene, the activities are shown 
relative to the pGL3 constructs 
cotransfected with the control 
empty pcDNA3.1. Firefly luciferase 
activities were normalized against 
the cotransfected β-galactosidase 
activity. Bars, SD; *p<0.01, 
***p<0.001. AU, arbitrary units.
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retina and is expressed in the zebrafish neural retina at 48 h 
post fertilization [30,31]. Slc6a9 is specifically expressed in 
the glycinergic amacrine cells where it plays an important 
role in glycine uptake, and controls N-methyl-D-aspartic acid 
receptor coagonist occupancy in the mouse retina [32]. The 
role of both genes in the retina needs to be further inves-
tigated. However, their expression seemed to be totally or 
partially compensated at P60, suggesting that Hmx1 does 
not solely regulate them. The positive deregulation of Sgcg 
in qPCR was impressive (about 1,000-fold), but it did not 
correlate with a higher amount of proteins in dmbo retina. 
It is likely that Sgcg was strongly regulated at the level of 
translation, which would explain why this dramatic increase 
in transcripts had no effect on the protein level, as shown 
for other genes related to cell adhesion [33]. In addition, the 
overexpressed γ-sarcoglycan could form aggregates that 
could be degraded in the endoplasmic reticulum, as supported 
by the proteolysis process enrichment in MetaCore analysis 
(Figure 1B). The role of the sgcg gene in the dmbo retinal 
phenotype remains unclear. Another finding resulting from 
the microarray analysis was that Hmx1 could act in vivo as a 
transcriptional repressor or activator. The first in vitro study 
conducted by Ament et al. showed only a repressor effect, 
but their work was done in HeLa cells indicating that cellular 
context may play a role in mediating HMX1 activity [12].
The second part of our study consisted of using our 
PPM to screen the genome and discover other putative 
targets of HMX1. More precisely, we focused our attention 
on identifying HMX1 targets that could be involved in eye 
development. This would help in understanding the bases 
of the human oculoauricular syndrome caused by Hmx1 
mutation [5]. The first method consisted of using the PPM 
to screen the RefSeq database of mouse and human. This 
method retrieved a large but expected number of genes 
despite the short screening window used. Many of these 
genes represented interesting candidates (see Appendix 1 for 
a complete list). To be more selective, we crossed human and 
mouse selections to keep only genes fitting the PPM in both 
species. Among the ten genes that we retrieved, four have 
been reported to be expressed in the eye, during develop-
ment (EPHA6, MARCKS, and UHRF1), or during adult life 
(SEPT4) [34-37]. In addition, SH3KBP1 was predicted to be 
a target of HMX1 and is highly expressed in Schwann cells, 
where the gene is regulated by SOX10 [38]. Interestingly, 
a recent study showed that a balance between SOX10 and 
HMX1 regulates neuronal versus Schwann cell precursor 
and melanocyte fates [39]. Our second method based on the 
co-occurrence of HMX1-BS pairs retrieved ten genes in the 
mouse genome and eight in the human genome. EPHA6, 
UHRF1, and SH3KBP1 were identified by both methods, 
increasing the confidence that these three targets were 
true targets. In the mouse, the Epha6 promoter showed the 
highest number of HMX1-BS pair combinations with four 
sites located within [-250,+200]. A wider examination of the 
region surrounding its TSS showed additional HMX1-BS 
clusters fitting the PPM in the proximal promoter and in the 
first intron. With Ptpro and Sema3f, Epha6 belongs to the 
retinal axon guidance pathway and plays an important role 
in retinotopic mapping [27,28,34,40,41]. In addition, these 
three predicted targets occupy key places as inputs of the 
axon repulsion signaling pathway, supporting a specific and 
effective action of Hmx1 in this process (see Figure 7 for more 
details). Finally, the strong and highly significant enrich-
ment of this pathway in the mouse selection obtained with 
HMX1-BS pairs co-occurrence based method underlined 
the likely role of Hmx1 in establishing retinal topography. 
The luciferase assay results provided experimental evidences 
to validate this hypothesis. For a positive control, we first 
showed that Hmx1 could act as a repressor and decrease the 
activity of the Sgcg promoter in the N2A cells. This result 
was expected based on the dramatic increase of Sgcg expres-
sion in dmbo mice. Then, we showed that Hmx1 represses 
the activity of Ptpro and Sema3f promoters. In the future, we 
will specifically focus our efforts on the functional study of 
Epha6, all the more so as the Ephrin pathway was already 
considered by Schorderet et al. to be a putative target of Hmx1 
[5]. We also noted that the human selection contained a new 
interesting gene expressed in the eye, FOXP1 [42], in addi-
tion to UHRF1 and EPHA6. Finally, some of the remaining 
predicted targets unrelated to the eye could be potential 
HMX1, NKX2–5, or HMX3 targets in other tissues and will 
need further investigation.
Several recurrent questions about TFBS identification 
arose from our study. The first concerns the conservation 
of CRMs between human and mouse. In fact, we observed 
poor conservation of our PPM between both species, whereas 
numerous studies showed that evolutionary conserved regions 
overlap functional regulatory elements (reviewed in [11]). 
Actually, approaches integrating comparative genomics 
data succeed to identify CRMs with a high positive predic-
tive value but overlook CRMs specific for a given species. 
Single-genome bioinformatic approaches are more conve-
nient to solve this problem. In this manner, a study based on 
the empirical potential energy of TFs revealed that CRMs 
occur in conserved and non-conserved regions, and about 
55% have a poor conservation score [43]. In particular, this 
study underlined that the less well-conserved CRMs concern 
genes related to neural activity. It could be explained by the 
fact that the nervous system function is specific for species, 
in contrast with more fundamental processes as transcription, 
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for example. Prediction of neural specific TFBSs appears 
to be harder than others; fortunately, it has been shown 
that homotypic CRMs are a good predictor of regulatory 
elements, especially for target genes related to TFs involved 
in neural development [17]. In a general way, homotypic 
CRMs are strongly associated with the region surrounding 
the TSS and the developmental enhancers, with no systematic 
phylogenetic conservation. These observations rationalize 
the results we obtained with a single-genome approach and 
the PPM-based method focused on the co-occurrence of 
HMX1-BS pairs, in particular with the mouse axon guidance 
pathway enrichment. Finally, we think that adding a distance 
range constraint to the PPM gave more accurate results than 
simply counting the TFBSs in the screening window. Actu-
ally, optimal distances for interactions are supposed to be 
specific for a given TF and including this parameter in the 
model should give more specific results [26].
In conclusion, our strategy was successful in identifying 
HMX1 targets because the PPM we constructed based on 
the P15 microarray data revealed, a posteriori, an important 
pathway involved in retinal development (I.E., axon repulsion 
during retinal axon guidance) in addition to the first three 
targets (I.E., Sgcg, Tshz2, and Slc6a9). These subsequent 
outcomes provided additional proof of the robustness of 
our PPM approach, and open up new opportunities to focus 
experimental investigations on this specific aspect of the 
Hmx1 pathway.
Figure 7. Mouse axon guidance pathway map. Adapted from the mmu04360 KEGG pathway. EphA6, Sema3F, and PTPRO are localized in 
red in the pathway. Note that PTPRO was originally absent from the map. Outputs of the ephrin and semaphorin pathways are underlined 
with red dotted lines. Green boxes: genes or gene products; rounded white boxes: connected pathways; solid arrows: direct interactions; 
dotted arrows: indirect interactions. Normal arrows symbolize activation, headless arrows symbolize inhibition.
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APPENDIX 1. OFFICIAL GENE SYMBOLS AND 
GENE ACCESSION NUMBERS OF ALL PREDICTED 
TARGETS.
To access the data, click or select the words “Appendix 1.”
APPENDIX 2. SEQUENCES AND AMPLICON SIZES 
OF QPCR PRIMER PAIRS USED IN THIS STUDY.
To access the data, click or select the words “Appendix 2.”
APPENDIX 3 UPREGULATED GENES WITH A 
FDR<0.1 AND A FOLD-CHANGE>1.2.
To access the data, click or select the words “Appendix 3.” 
#Orientation of HMX1-BSs are indicated; F, forward strand 
(CAAGTG); R, reverse strand (CACTTG).
APPENDIX 4. DOWNREGULATED GENES WITH A 
FDR<0.1 AND A FOLD-CHANGE>1.2.
To access the data, click or select the words “Appendix 4.” 
#Orientation of HMX1-BSs are indicated; F, forward strand 
(CAAGTG); R, reverse strand (CACTTG).
APPENDIX 5. GENE FUNCTIONAL 
CLASSIFICATION OF FDR<0.1 DIFFERENTIALLY 
EXPRESSED GENES ACCORDING TO DAVID 
SOFTWARE.
To access the data, click or select the words “Appendix 5.”
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